AI stocks

搜索文档
Jim Cramer Highlights FedEx Pressure from Loss of Chinese Tariff Exemption
Yahoo Finance· 2025-09-19 03:25
FedEx Corporation (NYSE:FDX) is one of the stocks on Jim Cramer’s radar. The company was part of Cramer’s game plan, and he said: “After the close, FedEx reports and the analysts have been lowering numbers and lowering numbers because of an expected decline in Chinese packages, now that they no longer have that tariff exemption.” pio3 / Shutterstock.com FedEx Corporation (NYSE:FDX) provides a range of services in transportation, e-commerce solutions, and business support. The company’s services includ ...
Is CVS Health a Defensive Pick Among the Best Performing in 2025 Dividend Stocks?
Yahoo Finance· 2025-09-18 20:40
CVS Health Corporation (NYSE:CVS) is included among the 15 Best Performing Dividend Stocks So Far in 2025. Is CVS Health a Defensive Pick Among the Best Performing in 2025 Dividend Stocks? CVS Health Corporation (NYSE:CVS) is an American multinational healthcare company. It has grown far beyond being just a pharmacy chain. Alongside filling prescriptions, the company runs in-store clinics that provide services such as lab tests, health screenings, vaccinations, and basic treatments for minor injuries. Th ...
Tesla, Inc. (TSLA)’s Board Chair Dismisses Concerns About Elon Musk’s Political Activities
Yahoo Finance· 2025-09-18 15:25
Tesla, Inc. (NASDAQ:TSLA) is among the 15 Stocks ChatGPT Predicts Could Make You Wealthy in 5 Years. Recently, board chair Robyn Denholm dismissed concerns about Elon Musk’s political activities adversely affecting sales at the EV maker, while adding that the billionaire was still front and center at the company. Tesla, Inc. (TSLA)'s Board Chair Dismisses Concerns About Elon Musk's Political Activities Photo by Tesla Fans Schweiz on Unsplash Denholm stated the following in an interview with Bloomberg on ...
Amazon.com, Inc. (AMZN) Tests GM’s BrightDrop Electric Vans In Bid To Meet Climate Goals
Yahoo Finance· 2025-09-18 15:21
Amazon.com, Inc. (NASDAQ:AMZN) is among the 15 Stocks ChatGPT Predicts Could Make You Wealthy in 5 Years. The e-commerce giant has recently begun testing GM’s BrightDrop electric vans as part of plans to have 100,000 electric delivery vehicles on the road by the end of the decade. Amazon.com, Inc. (AMZN) Tests GM’s BrightDrop Electric Vans In Bid To Meet Climate Goals christian-wiediger-rymh7EZPqRs-unsplash The company has been actively exploring options to reduce carbon emissions from its sprawling del ...
Cytokinetics (CYTK) Drops on $650-Million Debt Issuance
Yahoo Finance· 2025-09-18 15:19
We recently published 10 Big Names Investors Are Dumping. Cytokinetics, Inc. (NASDAQ:CYTK) is one of the worst performers on Wednesday. Shares of Cytokinetics dropped by 4.42 percent on Wednesday to end at $47.56 apiece after upsizing its senior convertible notes issuance to $650 million. In a statement, Cytokinetics, Inc. (NASDAQ:CYTK) said it aimed to raise $650 million from the offer, an increase from the $550 million targeted initially. The notes carry a yield rate of 1.75 percent until 2031 and will ...
Advisors Capital Boosts Netflix, Inc. (NFLX) Stake as Company Partners with Amazon Ads
Yahoo Finance· 2025-09-18 14:56
Netflix, Inc. (NASDAQ:NFLX) is among the high growth mega cap stocks you can buy and hold for the next 3 years. According to the latest Form 13F filing with the SEC, Advisors Capital Management LLC has expanded its holdings in Netflix, Inc. (NASDAQ:NFLX) by 5.0% in the first quarter. With the acquisition of an additional 443 shares, the financial advisory firm now owns 9,222 shares of the company’s stock, valued at $8,600,000. Last week, Netflix, Inc. (NASDAQ:NFLX) announced its partnership with Amazon Ad ...
Howmet Aerospace (HWM) Benefited From Demand And Extended Backlogs For New Aircraft
Yahoo Finance· 2025-09-18 13:44
Macquarie Asset Management, an investment management company, released its “Macquarie Core Equity Fund” investor letter for the second quarter of 2025. A copy of the letter can be downloaded here. The US large-cap equity market surged in Q2 2025, with the S&P 500® Index rising 10.94%. The equity market’s strength was due to reduced concerns over the possibility of President Trump quickly imposing harsh tariffs. Later, the administration put a pause on the tariff implementation. In this environment, the Macq ...
What Makes Penumbra (PEN) a Good Investment?
Yahoo Finance· 2025-09-18 12:48
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities strongly rebounded in the second quarter. The S&P 500 Index returned 10.9%, and the benchmark Russell 3000 Index advanced 11.0%, as risk-on sentiment took hold following the pause in tariff implementation. The strategy outperformed the benchmark in the quarter, driven by the strength in portfolio construction acr ...
What Makes Verisk Analytics (VRSK) a Must-Have For Major Insurance Companies?
Yahoo Finance· 2025-09-18 12:37
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities strongly rebounded in the second quarter. The S&P 500 Index returned 10.9%, and the benchmark Russell 3000 Index advanced 11.0%, as risk-on sentiment took hold following the pause in tariff implementation. The strategy outperformed the benchmark in the quarter, driven by the strength in portfolio construction acr ...
Where is Halozyme Therapeutics (HALO) Headed According to Analysts?
Yahoo Finance· 2025-09-17 18:27
Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best affordable biotech stocks to invest in now. On August 18, Morgan Stanley raised the firm’s price target on Halozyme Therapeutics, Inc. (NASDAQ:HALO) to $80 from $75, keeping an Overweight rating on the shares. Is Halozyme Therapeutics, Inc. (HALO) the Unstoppable Growth Stock to Invest in Now? The firm told investors in a research note that the EPS 2025 guidance for Halozyme Therapeutics, Inc. (NASDAQ:HALO) has increased by 20% since January, f ...